Armistice Capital, LLC Incyte Corp Transaction History

Armistice Capital, LLC

$6.02 Billion
Q3 2024

A detailed history of Armistice Capital, LLC transactions in Incyte Corp stock. As of the latest transaction made, Armistice Capital, LLC holds 2,196,105 shares of INCY stock, worth $155 Million. This represents 2.41% of its overall portfolio holdings.

Number of Shares

2,196,105

Previous 1,764,000 24.5%

Holding current value

$155 Million

Previous $107 Million 35.75%

% of portfolio

2.41%

Previous 1.39%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $24.8 Million - $29.6 Million	432,105 Added 24.5%	2,196,105 $145 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $21.7 Million - $27 Million	-423,181 Reduced 19.35%	1,764,000 $107 Million
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $110 Million - $130 Million	1,951,181 Added 826.77%	2,187,181 $125 Million
Q4 2023 Feb 13, 2024	SELL	$52.16 - $64.19 $41.7 Million - $51.4 Million	-800,000 Reduced 77.22%	236,000 $14.8 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $42.7 Million - $48.8 Million	-740,000 Reduced 41.67%	1,036,000 $59.8 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $5.85 Million - $7.25 Million	-96,000 Reduced 5.13%	1,776,000 $111 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $32.3 Million - $39.6 Million	460,000 Added 32.58%	1,872,000 $135 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $64.1 Million - $80.2 Million	-954,000 Reduced 40.32%	1,412,000 $113 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $24.2 Million - $30.3 Million	366,000 Added 18.3%	2,366,000 $158 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $31.5 Million - $39.6 Million	476,000 Added 31.23%	2,000,000 $152 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $41.7 Million - $50.4 Million	-632,000 Reduced 29.31%	1,524,000 $121 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $13.7 Million - $16 Million	-216,000 Reduced 9.11%	2,156,000 $158 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $96.7 Million - $118 Million	1,408,000 Added 146.06%	2,372,000 $163 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $5.43 Million - $5.95 Million	-68,000 Reduced 6.59%	964,000 $81.1 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $26.9 Million - $35.6 Million	354,000 Added 52.21%	1,032,000 $83.9 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $3.39 Million - $4.1 Million	42,000 Added 6.6%	678,000 $59 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $17 Million - $21.9 Million	200,000 Added 45.87%	636,000 $57.1 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $6.82 Million - $10 Million	-92,000 Reduced 17.42%	436,000 $45.3 Million
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $16 Million - $21.8 Million	253,000 Added 92.0%	528,000 $38.7 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $11.2 Million - $14.6 Million	-153,000 Reduced 35.75%	275,000 $24 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $14.6 Million - $17.3 Million	200,000 Added 87.72%	428,000 $31.8 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $16.8 Million - $20.2 Million	228,000 New	228,000 $19.4 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $6.36 Million - $8.82 Million	-100,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $19.2 Million - $22.9 Million	-328,000 Reduced 76.64%	100,000 $6.36 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $26 Million - $35.9 Million	428,000 New	428,000 $28.7 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $13.7 Million - $17 Million	-146,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $15.9 Million - $20.2 Million	146,000	146,000 $17 Million

Others Institutions Holding INCY

# of Institutions

645

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account

Armistice Capital, LLC Incyte Corp Transaction History